Allogene Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Allogene Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2019 to Q3 2024.
  • Allogene Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 1.17K %, a 21.1% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.17K +205 +21.1% Sep 30, 2024
Q2 2024 1.25K +286 +29.6% Jun 30, 2024
Q1 2024 1.14K +125 +12.2% Mar 31, 2024
Q4 2023 1.02K -123 -10.8% Dec 31, 2023
Q3 2023 968 -177 -15.4% Sep 30, 2023
Q2 2023 965 -110 -10.2% Jun 30, 2023
Q1 2023 1.02K -93.2 -8.38% Mar 31, 2023
Q4 2022 1.14K +5.94 +0.52% Dec 31, 2022
Q3 2022 1.14K +72.2 +6.73% Sep 30, 2022
Q2 2022 1.07K -156 -12.7% Jun 30, 2022
Q1 2022 1.11K -272 -19.7% Mar 31, 2022
Q4 2021 1.13K -334 -22.8% Dec 31, 2021
Q3 2021 1.07K -791 -42.5% Sep 30, 2021
Q2 2021 1.23K -610 -33.1% Jun 30, 2021
Q1 2021 1.38K -193 -12.2% Mar 31, 2021
Q4 2020 1.47K -83.6 -5.39% Dec 31, 2020
Q3 2020 1.86K +329 +21.4% Sep 30, 2020
Q2 2020 1.84K +1.17K +175% Jun 30, 2020
Q1 2020 1.58K Mar 31, 2020
Q4 2019 1.55K Dec 31, 2019
Q3 2019 1.53K Sep 30, 2019
Q2 2019 670 Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.